Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Oltenfreiter

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agentsRuth Oltenfreiter, Ludovicus Staelens, Soraya Labied, et al.
Journal of Molecular Biology|June 30, 2007
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivityAnna Tochowicz, Klaus Maskos, Robert Huber, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 21, 2006
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agentsRuth Oltenfreiter, Ludovicus Staelens, Veerle Kersemans, et al.
Current Pharmaceutical Design|January 24, 2013
Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECTNathalie Matusiak, Aren van Waarde, Rainer Bischoff, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 22, 2010
Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agentMagali Van Steenkiste, Ruth Oltenfreiter, Francis Frankenne, et al.
Nuclear Medicine and Biology|November 9, 2010
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cellsChristel Vangestel, Marc Peeters, Ruth Oltenfreiter, et al.
Molecular Imaging|April 28, 2011
In vivo imaging of apoptosis in oncology: an updateChristel Vangestel, Marc Peeters, Gilles Mees, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agentsRuth Oltenfreiter, Ludovicus Staelens, Soraya Labied, et al.
Journal of Molecular Biology|June 30, 2007
Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivityAnna Tochowicz, Klaus Maskos, Robert Huber, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 21, 2006
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agentsRuth Oltenfreiter, Ludovicus Staelens, Veerle Kersemans, et al.
Current Pharmaceutical Design|January 24, 2013
Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECTNathalie Matusiak, Aren van Waarde, Rainer Bischoff, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 22, 2010
Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agentMagali Van Steenkiste, Ruth Oltenfreiter, Francis Frankenne, et al.
Nuclear Medicine and Biology|November 9, 2010
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cellsChristel Vangestel, Marc Peeters, Ruth Oltenfreiter, et al.
Molecular Imaging|April 28, 2011
In vivo imaging of apoptosis in oncology: an updateChristel Vangestel, Marc Peeters, Gilles Mees, et al.
Pageof 2